🇺🇸 FDA
Pipeline program

PEMBROLIZUMAB , IMFINZI 50 mg/mL concentrate for solution for infusion., JZP598, Cisplatinum Accord, 1 mg/ml, koncentrat do sporządzania roztworu do infuzji., Gemcitabin Hikma 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung

JZP598-302

Phase 3 small_molecule active

Quick answer

PEMBROLIZUMAB , IMFINZI 50 mg/mL concentrate for solution for infusion., JZP598, Cisplatinum Accord, 1 mg/ml, koncentrat do sporządzania roztworu do infuzji., Gemcitabin Hikma 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung for BTC - Biliary Tract Cancer is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals Ireland Limited
Indication
BTC - Biliary Tract Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials